Pandemic Perspectives: Safety Monitoring Boost For COVID Vaccines Creating ‘A New Normal’ For Pharmacovigilance

Pink Sheet infographic puts together the many new and existing safety systems being used to track and evaluate COVID-19 vaccine adverse events. There are early signs the vaccination effort has led to heightened public attention on medication safety that may be here to stay.

puzzle pieces with Pandemic Perspectives logo
• Source: Shutterstock

COVID-19 vaccines are being subject to heightened safety scrutiny because of the speed of their development and regulatory clearance under the emergency use authorization pathway and because of the unusual amount of public attention on the rollout, given the vaccines potential to dampen a global pandemic. A third unique element is the evolving nature of the virus the vaccines are targeting.

Pandemic Perspectives

One year on from the World Health Organization declaring COVID-19 a global pandemic on 11 March 2020, editors across Informa Pharma Intelligence publications are taking a closer look at its impact and possible lasting implications for the biopharma and medtech industry.

To address the unusual challenge, the US has upped its safety efforts, creating two new pharmacovigilance systems for COVID-19 vaccines...

More from Vaccines

More from Pink Sheet